Comparison of above-the-knee prosthetic femoro- popliteal bypass versus percutaneous transluminal angioplasty and stenting for treatment of occlusive superficial femoral artery disease

Scandinavian Journal of Surgery

Volumn 102, Issue 4, 2013, Pages 227-233

  Linnakoski, H ^a   Uurto, I ^a,b   Suominen, V ^a,b   Vakhitov, D ^a,b   Salenius, J ^a,b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Above knee; Endovascular treatment; Percutaneous transluminal angioplasty; Peripheral artery disease; Peripheral bypass surgery; Revascularization; Stenting; Superficial femoral artery

Indexed keywords

AGED; ANGIOPLASTY; BLOOD VESSEL TRANSPLANTATION; COMPARATIVE STUDY; EVALUATION STUDY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RETROSPECTIVE STUDY; STENT; SURGERY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 84902655394     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1457496913501591     Document Type: Article

References (22)

1. Norgren L, Hiatt WR, Dormandy JA, et al: Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45(Suppl. S):S5-67.
2. Sigvant B, Wiberg-Hedman K, Bergqvist D, et al: A population- based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007;45:1185-1191.
3. Caro J, Migliaccio-Walle K, Ishak KJ, et al: The morbidity and mortality following a diagnosis of peripheral arterial disease: Long-term follow-up of a large database. BMC Cardiovasc Disord 2005;5:14.
4. Norgren L, Hiatt WR, Dormandy JA, et al: The next 10 years in the management of peripheral artery disease: Perspectives from the "PAD 2009" Conference. Eur J Vasc Endovasc Surg 2010;40:375-380.
5. R utherford RB, Flanigan DP, Gupta SK, et al: Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986;4:80-94.
6. Adam DJ, Beard JD, Cleveland T, et al: Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised, controlled trial. Lancet 2005;366:1925-1934.
7. Kukkonen T, Korhonen M, Halmesmäki K, et al: Poor inter-observer agreement on the TASC II classification of femoropopliteal lesions. Eur J Vasc Endovasc Surg 2010;39: 220-224.
8. Scali ST, Rzucidlo EM, Bjerke AA, et al: Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease. J Vasc Surg 2011;54: 714-721.
9. Faglia E, Clerici G, Airoldi F, et al: Revascularization by angioplasty of type D femoropopliteal and long infrapopliteal lesion in diabetic patients with critical limb ischemia: Are TASC II recommendations suitable? A population-based cohort study. Int J Low Extrem Wounds 2012;11:277-285.
10. Baril DT, Chaer RA, Rhee RY, et al: Endovascular interventions for TASC II D femoropopliteal lesions. J Vasc Surg 2010;51:1406-1412.
11. Siracuse JJ, Giles KA, Pomposelli FB, et al: Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease. J Vasc Surg 2012;55:1001-1007.
12. Arvela E, Venermo M, Söderström M, et al: Infrainguinal percutaneous transluminal angioplasty or bypass surgery in patients aged 80 years and older with critical leg ischaemia. Br J Surg 2011;98:518-526.
13. Schmieder GC, Panneton JM: Endovascular superficial femoral artery treatment: Can it be as good as bypass? Semin Vasc Surg 2008;21:186-194.
14. Hunink MG, Wong JB, Donaldson MC, et al: Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 1994;14:71-81.
15. McQuade K, Gable D, Hohman S, et al: Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2009;49:109-115.
16. Dosluoglu HH, Cherr GS, Lall P, et al: Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease. J Vasc Surg 2008;48:1166-1174.
17. Clair D, Shah S, Weber J: Current state of diagnosis and management of critical limb ischemia. Curr Cardiol Rep 2012;14:160-170.
18. Korhonen M, Biancari F, Söderström M, et al: Femoropopliteal balloon angioplasty vs. bypass surgery for CLI: A propensity score analysis. Eur J Vasc Endovasc Surg 2011;41:378-384.
19. Van der Zaag ES, Legemate DA, Prins MH, et al: Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg 2004;28:132-137.
20. Nasr MK, McCarthy RJ, Hardman J, et al: The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia. Eur J Vasc Endovasc Surg 2002;23:398-403.
21. Kudo T, Chandra F, Kwun W-H, et al: Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs open bypass surgery. J Vasc Surg 2006;44:304-313.
22. Twine CP, McLain AD: Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev 2010;12:CD001487.